• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) VOLLURE (VOLUME UNKNOWN) IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) VOLLURE (VOLUME UNKNOWN) IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number UNK VOLLURE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Unspecified Infection (1930)
Event Type  Injury  
Manufacturer Narrative
The events are physiological complications and analysis of the device generally does not assist allergan in determining a probable cause for these events. Clarification: the filler was injected into the patient and is not accessible for return. The syringe was not returned for evaluation. This is a known potential adverse event addressed in the product labeling.
 
Event Description
Health professional reported injecting a patient in the cheeks with 1 cc of juvéderm voluma® xc and in the lips and nasolabial folds with 1 cc of juvéderm® ultra xc. The patient experienced a ¿nodule¿ in the right cheek and returned to the office a month after injection where ¿nodules and edema¿ were confirmed. The patient was treated with 5fu 50 ml and a steroid pack. The patient returned a week later with more ¿nodules¿ in the right cheek. The patient was treated 150 ml of hylenex, antibiotics, and a steroid injection. Two weeks later, the patient was treated with 100 ml of hylenex. The patient was currently on an antibiotic for a non-device related urinary tract infection. Three weeks later, the patient reported the nodules were worsening in the right cheek and ¿facial palsy (not related to the device)" on the right side. The patient has a previous injection in the marionette lines with juvéderm vollure¿ xc and experienced ¿an infection with an abscess¿ that had to be drained. The event is ongoing. This is the same event and the same patient reported under mdr id# 3005113652-2020-00785 (allergan complaint # (b)(4)) and mdr id# 3005113652-2020-00782 (allergan complaint # (b)(4)). This mdr is being submitted for the previous suspect product, juvéderm vollure¿ xc.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameVOLLURE (VOLUME UNKNOWN)
Type of DeviceIMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR 74370
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy 74370
FR 74370
Manufacturer Contact
michelle burgess
12331-a riata trace parkway
building 3
austin, TX 78727
7372473605
MDR Report Key11043566
MDR Text Key222646046
Report Number3005113652-2020-00783
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation
Type of Report Initial
Report Date 12/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Catalogue NumberUNK VOLLURE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received11/24/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage

Patient Treatment Data
Date Received: 12/20/2020 Patient Sequence Number: 1
Treatment
ENBREL, STEROIDS
-
-